Bath & Body Works BBWI
- Market cap
- $4.2B
- PE
- 5.5×
- 10y median 9.4×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 0.6×
- EV/EBIT
- 5.8×
- Revenue, 12 months
- $7.2B
- −2% on a year ago
- Net margin
- 10.8%
- Free cash flow yield
- 24.4%
Bath & Body Works trades at 5.5× trailing earnings, cheaper than 97% of the last ten years. Revenue was $7.2B over the last twelve months, down 2% on a year earlier with a 11% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.6B−3% | $2.9B+1% | $1.4B−1% | $1.5B−2% | $1.6B+3% | $2.8B−4% | $1.4B+3% | $1.5B+2% | $1.6B−1% | $2.7B−2% | $1.4B−3% | $1.5B−2% | |
| Cost of revenue | $880M−5% | $1.6B−4% | $778M−3% | $900M−4% | $910M+3% | $1.5B−6% | $778M+0% | $909M+1% | $936M+3% | $1.5B−0% | $791M+2% | $822M−10% |
| Gross profit | $682M+1% | $1.3B+7% | $606M+2% | $626M+1% | $700M+3% | $1.3B−3% | $646M+7% | $640M+2% | $658M−6% | $1.2B−4% | $587M−9% | $692M+8% |
| SG&A | $461M−3% | $641M+7% | $419M+1% | $443M+2% | $482M+5% | $623M−3% | $437M+4% | $483M+9% | $497M+3% | $645M+4% | $356M−19% | $476M−1% |
| $221M+9% | $696M+7% | $187M+3% | $183M−3% | $218M−1% | $678M−3% | $209M+12% | $157M−14% | $161M−26% | $599M−12% | $231M+11% | $216M+38% | |
| Interest expense | $84M−2% | $86M+0% | $82M−8% | $77M−11% | $77M−8% | $76M−12% | $71M−13% | $68M−12% | $68M−12% | $68M−11% | $69M−3% | $63M−7% |
| Pre-tax income | $159M+34% | $623M+8% | $118M+5% | $153M+21% | $145M−9% | $611M−2% | $146M+24% | $95M−38% | $103M−29% | $538M−12% | $166M+14% | $164M+73% |
| $40M+43% | $44M−70% | $31M+0% | $1M−96% | $39M−3% | $158M+259% | $41M+32% | $31M+3000% | $26M−33% | $135M−15% | −$17M | $46M+48% | |
| Net income | $119M+31% | $579M+33% | $87M+7% | $152M+54% | $106M−11% | $453M−22% | $105M+21% | $64M−58% | $77M−27% | $403M−11% | $183M+74% | $118M+84% |
| $0.52+30% | $2.53+34% | $0.38+9% | $0.68+58% | $0.49−6% | $2.11−17% | $0.49+29% | $0.30−56% | $0.37−25% | $1.99−6% | $0.90+84% | $0.58+93% | |
| 228M−0% | 229M+1% | 226M−2% | 223M−3% | 219M−4% | 215M−6% | 215M−5% | 211M−5% | 206M−6% | 203M−6% | 202M−6% | 202M−4% |
EPS, diluted: Q4 FY09: quarter's net income to common over its shares, to the cent, the shares from counts implied by EPS, near the year's EPS less the nine months'. 5 periods, Q3 FY10 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 13 periods, Q4 FY09 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY19: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Specialty Retail nearest Bath & Body Works' size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| BBWIBath & Body Works | $4.2B | 5.5× | 9.4× | 0.6× | −2% | 10.8% | |
| SIGSignet Jewelers | $4.5B | 13.5× | 10.1× | 0.7× | +1% | 5.2% | |
| ASOAcademy Sports & Outdoors | $3.7B | 10.1× | 8.1× | 0.6× | +4% | 6.4% | |
| NSITInsight Enterprises | $5.2B | 25.9× | 17.0× | 0.6× | +3% | 2.5% | |
| AAPAdvance Auto Parts | $2.8B | 34.2× | 22.7× | 0.3× | −1% | 1.0% | |
| RHRH | $2.6B | 24.5× | 32.7× | 0.8× | +3% | 3.2% | |
| FCFSFirstCash | $7.5B | 19.7× | 23.2× | 1.8× | +22% | 9.4% | |
| GCTGigaCloud Technology | $2.1B | 13.8× | 8.7× | 1.4× | +23% | 10.6% | |
| CHWYChewy | $8.8B | 33.2× | 53.0× | 0.7× | +6% | 2.1% | |
| EZPWEzcorp | $1.8B | 14.6× | 17.6× | 1.1× | +29% | 10.0% | |
| ARHSArhaus | $1.7B | 23.4× | 17.5× | 1.2× | +5% | 4.9% | |
| Peer median | $3.3B | 21.6× | 17.5× | 0.7× | +5% | 5.0% |
More on Bath & Body Works
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #4of 232Consumer cyclical stocks with the lowest PE ratio
- #2of 24Specialty retail stocks cheapest against their own PE history
- #3of 35Specialty retail stocks with the lowest PE ratio
- #4of 45Specialty retail stocks with the highest free cash flow yield
- #8of 60Specialty retail stocks with the highest profit margins
- #6of 41Specialty retail stocks with the lowest EV/EBIT
Its groups
About
- Industry
- Specialty Retail
- Sector
- Consumer Cyclical
Valuation data, not investment advice. Prices as of .